Antimicrobial Stewardship-Driven Monoclonal Antibody Treatment Program for COVID-19 Patients in the Bronx, New York

Background: In November 2020, bamlanivimab received emergency use authorization (EUA) to treat patients with early, mild-to-moderate COVID-19 who are at high risk of progression. Montefiore Medical Center serves an economically underserved community of >1.4 million residents in the Bronx, New Yor...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yi, Chen, Victor, Allen, Lauren, Cowman, Kelsie, Hopkins, Una, Sheridan, Carol, Torres, Edwin A, Davis, Patricia, Sakalian, Susan, Sosnowski, Frank, Nori, Priya, Pirofski, Liise-anne, Haviland, Adam, Rossi, James, Bao, Hongkai (Jack)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551520/
http://dx.doi.org/10.1017/ash.2021.110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551520/
http://dx.doi.org/10.1017/ash.2021.110

Ejemplares similares